Evogene Ownership 2024 | Who Owns Evogene Now?


OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

7.98%

Insider Ownership

1.66%

Retail Ownership

90.36%

Institutional Holders

27.00

Evogene Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SILVERARC CAPITAL MANAGEMENT, LLC6.10%0.64%3,085,503-14,497-0.47%2,314,127Mar 31, 2024
MORGAN STANLEY0.56%-284,04895,60250.73%213,037Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC0.18%0.00%91,40021,50030.76%68,550Mar 31, 2024
LPL FINANCIAL LLC0.13%-66,835--50,126Mar 31, 2024
UBS GROUP AG0.12%-62,4956,49011.59%46,871Mar 31, 2024
CITADEL ADVISORS LLC0.12%-59,9113,1915.63%44,340Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.12%-59,007--43,671Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.09%0.00%44,800--34,000Mar 31, 2024
JPMORGAN CHASE & CO0.08%-39,430-25,164-38.96%29,573Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.0.08%-38,03415,74870.66%28,526,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.06%-32,49532,495100.00%24,050Mar 31, 2024
SIGMA PLANNING CORP0.06%0.00%31,7858,69837.67%23,839Mar 31, 2024
CSENGE ADVISORY GROUP0.06%0.00%30,762--23,067Mar 31, 2024
JOEL ISAACSON & CO., LLC0.06%0.00%30,300--22,725Mar 31, 2024
CITADEL ADVISORS LLC0.05%-23,00023,000100.00%17,022Mar 31, 2024
PRIVATE ADVISOR GROUP, LLC0.03%0.00%14,013--10,510Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP LTD.0.03%0.00%13,32113,321100.00%9,859Mar 31, 2024
MALAGA COVE CAPITAL, LLC0.02%0.00%12,000--9,000Mar 31, 2024
XTX TOPCO LTD0.02%0.00%11,56111,561100.00%8,556Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.02%-11,08911,089100.00%8,000Mar 31, 2024

Evogene's largest institutional shareholder is SILVERARC CAPITAL MANAGEMENT, LLC, holding 6.10% of the company's total share outstanding, currently valued at $2.31M. The top 10 institutional shareholders own together 7.57% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SILVERARC CAPITAL MANAGEMENT, LLC6.10%0.64%3,085,503-14,497-0.47%2,314,127Mar 31, 2024
MALAGA COVE CAPITAL, LLC0.02%0.00%12,000--9,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP LTD.0.03%0.00%13,32113,321100.00%9,859Mar 31, 2024
CSENGE ADVISORY GROUP0.06%0.00%30,762--23,067Mar 31, 2024
JOEL ISAACSON & CO., LLC0.06%0.00%30,300--22,725Mar 31, 2024
XTX TOPCO LTD0.02%0.00%11,56111,561100.00%8,556Mar 31, 2024
SIGMA PLANNING CORP0.06%0.00%31,7858,69837.67%23,839Mar 31, 2024
PRIVATE ADVISOR GROUP, LLC0.03%0.00%14,013--10,510Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC0.18%0.00%91,40021,50030.76%68,550Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.09%0.00%44,800--34,000Mar 31, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC0.01%-5,000--3,750Mar 31, 2024
0.01%-5,0005,000100.00%3,750Mar 31, 2024
LPL FINANCIAL LLC0.13%-66,835--50,126Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.0.08%-38,03415,74870.66%28,526,000Mar 31, 2024
MORGAN STANLEY0.56%-284,04895,60250.73%213,037Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.0.02%-8,425--6,319,000Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.02%-11,08911,089100.00%8,000Mar 31, 2024
UBS GROUP AG0.12%-62,4956,49011.59%46,871Mar 31, 2024
CITADEL ADVISORS LLC0.12%-59,9113,1915.63%44,340Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.06%-32,49532,495100.00%24,050Mar 31, 2024

The largest Evogene shareholder by % of total assets is SILVERARC CAPITAL MANAGEMENT, LLC. The company owns 3.09M shares of Evogene (EVGN), representing 0.64% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MORGAN STANLEY0.56%-284,04895,60250.73%213,037Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.06%-32,49532,495100.00%24,050Mar 31, 2024
CITADEL ADVISORS LLC0.05%-23,00023,000100.00%17,022Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC0.18%0.00%91,40021,50030.76%68,550Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.0.08%-38,03415,74870.66%28,526,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP LTD.0.03%0.00%13,32113,321100.00%9,859Mar 31, 2024
XTX TOPCO LTD0.02%0.00%11,56111,561100.00%8,556Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.02%-11,08911,089100.00%8,000Mar 31, 2024
SIGMA PLANNING CORP0.06%0.00%31,7858,69837.67%23,839Mar 31, 2024
UBS GROUP AG0.12%-62,4956,49011.59%46,871Mar 31, 2024
0.01%-5,0005,000100.00%3,750Mar 31, 2024
CITADEL ADVISORS LLC0.12%-59,9113,1915.63%44,340Mar 31, 2024
TORONTO DOMINION BANK--20--15Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.00%-50--37Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.12%-59,007--43,671Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.0.02%-8,425--6,319,000Mar 31, 2024
LPL FINANCIAL LLC0.13%-66,835--50,126Mar 31, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC0.01%-5,000--3,750Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.09%0.00%44,800--34,000Mar 31, 2024
PRIVATE ADVISOR GROUP, LLC0.03%0.00%14,013--10,510Mar 31, 2024

As of Mar 31 2024, Evogene's largest institutional buyer is MORGAN STANLEY. The company purchased 95.60K stocks of EVGN, valued at $213.04K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WALLEYE CAPITAL LLC----349,477-100.00%-Mar 31, 2024
CONNECTIVE CAPITAL MANAGEMENT, LLC----100,000-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----34,074-100.00%-Mar 31, 2024
JPMORGAN CHASE & CO0.08%-39,430-25,164-38.96%29,573Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC6.10%0.64%3,085,503-14,497-0.47%2,314,127Mar 31, 2024
TWO SIGMA SECURITIES, LLC----12,373-100.00%-Mar 31, 2024
SNS FINANCIAL GROUP, LLC----10,000-100.00%-Mar 31, 2024
CUTLER GROUP LLC / CA----2,600-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----2,100-100.00%-Mar 31, 2024
GROUP ONE TRADING, L.P.0.00%-126-1,001-88.82%93Mar 31, 2024
BANK OF AMERICA CORP /DE/0.00%-1,074-274-20.33%806,000Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----100-100.00%-Mar 31, 2024
MALAGA COVE CAPITAL, LLC0.02%0.00%12,000--9,000Mar 31, 2024
CSENGE ADVISORY GROUP0.06%0.00%30,762--23,067Mar 31, 2024
JOEL ISAACSON & CO., LLC0.06%0.00%30,300--22,725Mar 31, 2024
PRIVATE ADVISOR GROUP, LLC0.03%0.00%14,013--10,510Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.09%0.00%44,800--34,000Mar 31, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC0.01%-5,000--3,750Mar 31, 2024
LPL FINANCIAL LLC0.13%-66,835--50,126Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.0.02%-8,425--6,319,000Mar 31, 2024

As of Mar 31 2024, Evogene's biggest institutional seller is WALLEYE CAPITAL LLC. The company sold -0.35M shares of EVGN, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.06%-32,49532,495100.00%24,050Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP LTD.0.03%0.00%13,32113,321100.00%9,859Mar 31, 2024
XTX TOPCO LTD0.02%0.00%11,56111,561100.00%8,556Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.02%-11,08911,089100.00%8,000Mar 31, 2024
0.01%-5,0005,000100.00%3,750Mar 31, 2024

Evogene's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 32.49K shares, valued at $24.05K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WALLEYE CAPITAL LLC----349,477-100.00%-Mar 31, 2024
CONNECTIVE CAPITAL MANAGEMENT, LLC----100,000-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC----34,074-100.00%-Mar 31, 2024
TWO SIGMA SECURITIES, LLC----12,373-100.00%-Mar 31, 2024
SNS FINANCIAL GROUP, LLC----10,000-100.00%-Mar 31, 2024
CUTLER GROUP LLC / CA----2,600-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----2,100-100.00%-Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----100-100.00%-Mar 31, 2024

Evogene's largest sold out institutional shareholder by shares sold is WALLEYE CAPITAL LLC, sold -0.35M shares, valued at -, as of undefined.

Evogene Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%3,768--Dec 31, 2023

Evogene's largest mutual fund holder by % of total assets is "JOHN HANCOCK VARIABLE INSURANCE TRUST", owning 3.77K shares, compromising 0.00% of its total assets.

Evogene Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2427-6.90%
31 Dec, 2329-9.38%
30 Sep, 233228.00%
30 Jun, 23254.17%
31 Mar, 2324-7.69%
31 Dec, 222613.04%
30 Sep, 2223-14.81%
30 Jun, 2227-22.86%
31 Mar, 2235-10.26%
31 Dec, 2139-
30 Sep, 2139-9.30%
30 Jun, 2143-10.42%
31 Mar, 214860.00%
31 Dec, 203087.50%
30 Sep, 2016-
30 Jun, 20166.67%
31 Mar, 2015-
31 Dec, 1915-11.76%
30 Sep, 1917-
30 Jun, 1917-19.05%
31 Mar, 1921-8.70%
31 Dec, 1823-
30 Sep, 1823-
30 Jun, 1823-8.00%
31 Mar, 18254.17%
31 Dec, 172433.33%
30 Sep, 1718-14.29%
30 Jun, 1721-4.55%
31 Mar, 1722-
31 Dec, 162222.22%
30 Sep, 1618-
30 Jun, 1618-14.29%
31 Mar, 162110.53%
31 Dec, 15195.56%
30 Sep, 1518-
30 Jun, 151812.50%
31 Mar, 15166.67%
31 Dec, 1415-
30 Sep, 1415-
30 Jun, 1415-16.67%
31 Mar, 14185.88%
31 Dec, 1317-

As of 31 Mar 24, 27 institutions are holding Evogene's shares, representing a decrease of -6.90% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 244,038,484-5.27%
31 Dec, 234,263,376-2.82%
30 Sep, 234,387,025532.01%
30 Jun, 23694,139-9.69%
31 Mar, 23768,577-27.69%
31 Dec, 221,062,917-26.04%
30 Sep, 221,437,075-7.87%
30 Jun, 221,559,836-34.64%
31 Mar, 222,386,650-59.71%
31 Dec, 215,923,403-4.21%
30 Sep, 216,183,963-15.53%
30 Jun, 217,321,262-11.71%
31 Mar, 218,292,075-12.83%
31 Dec, 209,512,41312.20%
30 Sep, 208,478,17336.82%
30 Jun, 206,196,365-15.26%
31 Mar, 207,312,4208.55%
31 Dec, 196,736,377-10.44%
30 Sep, 197,521,386-0.08%
30 Jun, 197,527,241-13.25%
31 Mar, 198,676,785-4.81%
31 Dec, 189,115,5250.23%
30 Sep, 189,094,7030.30%
30 Jun, 189,067,253-1.47%
31 Mar, 189,202,857-0.20%
31 Dec, 179,220,84415.74%
30 Sep, 177,966,801-0.76%
30 Jun, 178,027,4212.84%
31 Mar, 177,805,5021.31%
31 Dec, 167,704,3671.28%
30 Sep, 167,606,6461.61%
30 Jun, 167,486,3352.04%
31 Mar, 167,336,6904.07%
31 Dec, 157,049,47310.48%
30 Sep, 156,380,8101.92%
30 Jun, 156,260,3115.66%
31 Mar, 155,925,0464.97%
31 Dec, 145,644,72713.97%
30 Sep, 144,952,85121.13%
30 Jun, 144,088,931-0.58%
31 Mar, 144,112,706-15.61%
31 Dec, 134,873,504-

Evogene (EVGN) has 4.04M shares outstanding as of 31 Mar 24, down -5.27% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 247.98%10.51%
31 Dec, 238.71%7.85%
30 Sep, 2310.53%376.34%
30 Jun, 231.67%48.75%
31 Mar, 231.85%27.84%
31 Dec, 222.58%21.21%
30 Sep, 223.49%24.33%
30 Jun, 223.79%11.27%
31 Mar, 225.79%2.80%
31 Dec, 2114.39%6.28%
30 Sep, 2115.14%4.65%
30 Jun, 2118.04%3.98%
31 Mar, 2121.28%2.74%
31 Dec, 2027.89%2.82%
30 Sep, 2031.43%5.43%
30 Jun, 2024.06%2.98%
31 Mar, 2028.39%4.15%
31 Dec, 1926.16%3.07%
30 Sep, 1929.20%3.42%
30 Jun, 1929.23%2.57%
31 Mar, 1933.69%2.69%
31 Dec, 1835.40%2.84%
30 Sep, 1835.31%2.85%
30 Jun, 1835.21%2.76%
31 Mar, 1835.74%2.78%
31 Dec, 1735.84%3.56%
30 Sep, 1731.71%3.42%
30 Jun, 1730.46%3.25%
31 Mar, 1730.60%3.37%
31 Dec, 1630.15%3.41%
30 Sep, 1629.75%3.26%
30 Jun, 1630.19%3.77%
31 Mar, 1628.29%3.65%
31 Dec, 1527.85%4.63%
30 Sep, 1524.53%3.83%
30 Jun, 1525.29%4.95%
31 Mar, 1522.59%4.45%
31 Dec, 1422.53%5.55%
30 Sep, 1420.15%7.26%
30 Jun, 1416.66%6.09%
31 Mar, 1416.54%3.10%
31 Dec, 1323.11%-

As of 31 Mar 24, Evogene is held by 7.98% institutional shareholders, representing a 10.51% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 241183.33%
31 Dec, 236-66.67%
30 Sep, 231850.00%
30 Jun, 231250.00%
31 Mar, 238-20.00%
31 Dec, 221042.86%
30 Sep, 22716.67%
30 Jun, 226-45.45%
31 Mar, 2211-45.00%
31 Dec, 212066.67%
30 Sep, 2112-29.41%
30 Jun, 2117-50.00%
31 Mar, 213441.67%
31 Dec, 2024118.18%
30 Sep, 201157.14%
30 Jun, 20740.00%
31 Mar, 205400.00%
31 Dec, 191-80.00%
30 Sep, 19525.00%
30 Jun, 194-50.00%
31 Mar, 19814.29%
31 Dec, 187-22.22%
30 Sep, 18912.50%
30 Jun, 18814.29%
31 Mar, 187-50.00%
31 Dec, 1714100.00%
30 Sep, 177-
30 Jun, 177-22.22%
31 Mar, 179-10.00%
31 Dec, 161066.67%
30 Sep, 166-14.29%
30 Jun, 167-36.36%
31 Mar, 1611-
31 Dec, 151122.22%
30 Sep, 15912.50%
30 Jun, 15860.00%
31 Mar, 155-28.57%
31 Dec, 14716.67%
30 Sep, 146100.00%
30 Jun, 143-50.00%
31 Mar, 146-64.71%
31 Dec, 1317-

11 institutional shareholders have increased their position in EVGN stock as of 31 Mar 24 compared to 6 in the previous quarter (a 83.33% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 244-42.86%
31 Dec, 23775.00%
30 Sep, 234-20.00%
30 Jun, 235-16.67%
31 Mar, 23620.00%
31 Dec, 225-
30 Sep, 225-58.33%
30 Jun, 221220.00%
31 Mar, 221011.11%
31 Dec, 219-47.06%
30 Sep, 2117-
30 Jun, 2117325.00%
31 Mar, 214-
31 Dec, 204-20.00%
30 Sep, 20525.00%
30 Jun, 204100.00%
31 Mar, 202-71.43%
31 Dec, 197133.33%
30 Sep, 193-50.00%
30 Jun, 19620.00%
31 Mar, 19525.00%
31 Dec, 18433.33%
30 Sep, 183-
30 Jun, 183-57.14%
31 Mar, 187250.00%
31 Dec, 172-
30 Sep, 172-33.33%
30 Jun, 173-25.00%
31 Mar, 174-20.00%
31 Dec, 16566.67%
30 Sep, 163-
30 Jun, 163-40.00%
31 Mar, 165-
31 Dec, 15--100.00%
30 Sep, 152-
30 Jun, 152-33.33%
31 Mar, 153-25.00%
31 Dec, 144-20.00%
30 Sep, 145-28.57%
30 Jun, 147-22.22%
31 Mar, 149-
31 Dec, 13--

4 institutional shareholders have reduced their position in EVGN stock as of 31 Mar 24 compared to 7 in the previous quarter (a -42.86% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2427-6.90%4,038,484-5.27%7.98%10.51%1183.33%4-42.86%
31 Dec, 2329-9.38%4,263,376-2.82%8.71%7.85%6-66.67%775.00%
30 Sep, 233228.00%4,387,025532.01%10.53%376.34%1850.00%4-20.00%
30 Jun, 23254.17%694,139-9.69%1.67%48.75%1250.00%5-16.67%
31 Mar, 2324-7.69%768,577-27.69%1.85%27.84%8-20.00%620.00%
31 Dec, 222613.04%1,062,917-26.04%2.58%21.21%1042.86%5-
30 Sep, 2223-14.81%1,437,075-7.87%3.49%24.33%716.67%5-58.33%
30 Jun, 2227-22.86%1,559,836-34.64%3.79%11.27%6-45.45%1220.00%
31 Mar, 2235-10.26%2,386,650-59.71%5.79%2.80%11-45.00%1011.11%
31 Dec, 2139-5,923,403-4.21%14.39%6.28%2066.67%9-47.06%
30 Sep, 2139-9.30%6,183,963-15.53%15.14%4.65%12-29.41%17-
30 Jun, 2143-10.42%7,321,262-11.71%18.04%3.98%17-50.00%17325.00%
31 Mar, 214860.00%8,292,075-12.83%21.28%2.74%3441.67%4-
31 Dec, 203087.50%9,512,41312.20%27.89%2.82%24118.18%4-20.00%
30 Sep, 2016-8,478,17336.82%31.43%5.43%1157.14%525.00%
30 Jun, 20166.67%6,196,365-15.26%24.06%2.98%740.00%4100.00%
31 Mar, 2015-7,312,4208.55%28.39%4.15%5400.00%2-71.43%
31 Dec, 1915-11.76%6,736,377-10.44%26.16%3.07%1-80.00%7133.33%
30 Sep, 1917-7,521,386-0.08%29.20%3.42%525.00%3-50.00%
30 Jun, 1917-19.05%7,527,241-13.25%29.23%2.57%4-50.00%620.00%
31 Mar, 1921-8.70%8,676,785-4.81%33.69%2.69%814.29%525.00%
31 Dec, 1823-9,115,5250.23%35.40%2.84%7-22.22%433.33%
30 Sep, 1823-9,094,7030.30%35.31%2.85%912.50%3-
30 Jun, 1823-8.00%9,067,253-1.47%35.21%2.76%814.29%3-57.14%
31 Mar, 18254.17%9,202,857-0.20%35.74%2.78%7-50.00%7250.00%
31 Dec, 172433.33%9,220,84415.74%35.84%3.56%14100.00%2-
30 Sep, 1718-14.29%7,966,801-0.76%31.71%3.42%7-2-33.33%
30 Jun, 1721-4.55%8,027,4212.84%30.46%3.25%7-22.22%3-25.00%
31 Mar, 1722-7,805,5021.31%30.60%3.37%9-10.00%4-20.00%
31 Dec, 162222.22%7,704,3671.28%30.15%3.41%1066.67%566.67%
30 Sep, 1618-7,606,6461.61%29.75%3.26%6-14.29%3-
30 Jun, 1618-14.29%7,486,3352.04%30.19%3.77%7-36.36%3-40.00%
31 Mar, 162110.53%7,336,6904.07%28.29%3.65%11-5-
31 Dec, 15195.56%7,049,47310.48%27.85%4.63%1122.22%--100.00%
30 Sep, 1518-6,380,8101.92%24.53%3.83%912.50%2-
30 Jun, 151812.50%6,260,3115.66%25.29%4.95%860.00%2-33.33%
31 Mar, 15166.67%5,925,0464.97%22.59%4.45%5-28.57%3-25.00%
31 Dec, 1415-5,644,72713.97%22.53%5.55%716.67%4-20.00%
30 Sep, 1415-4,952,85121.13%20.15%7.26%6100.00%5-28.57%
30 Jun, 1415-16.67%4,088,931-0.58%16.66%6.09%3-50.00%7-22.22%
31 Mar, 14185.88%4,112,706-15.61%16.54%3.10%6-64.71%9-
31 Dec, 1317-4,873,504-23.11%-17---

Evogene Peer Ownership


TickerCompany
LEXXLexaria Bioscience Corp.
ZVSAZyVersa Therapeutics, Inc.
CKPTCheckpoint Therapeutics, Inc.
BDRXBiodexa Pharmaceuticals Plc
FATEFate Therapeutics, Inc.
PLURPluri Inc.
CGENCompugen Ltd.
GMDAGamida Cell Ltd.
CLGNCollPlant Biotechnologies Ltd.
ONCROncorus, Inc.
CRVSCorvus Pharmaceuticals, Inc.
RCUSArcus Biosciences, Inc.
SURFSurface Oncology, Inc.
ALDXAldeyra Therapeutics, Inc.
ICCCImmuCell Corporation

EVGN Ownership FAQ


Evogene is owned by institutional shareholders (7.98%), insiders (1.66%), and public (90.36%). The largest institutional shareholder of Evogene is SILVERARC CAPITAL MANAGEMENT, LLC (6.10% of total shares) and the top mutual fund owner is JOHN HANCOCK VARIABLE INSURANCE TRUST (0.00% of total shares).

Evogene's major institutional shareholders are SILVERARC CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SNC, LPL FINANCIAL LLC, and UBS GROUP AG. The top five shareholders own together 7.10% of the company's share outstanding.

As of Mar 2024, there are 27 institutional shareholders of Evogene.

SILVERARC CAPITAL MANAGEMENT, LLC owns 3.09M shares of Evogene, representing 6.10% of the company's total shares outstanding, valued at $2.31M (as of Mar 2024).

As of Mar 2024, MORGAN STANLEY holds 284.05K shares of Evogene (EVGN), compromising 0.56% of the company, valued at $213.04K.

BNP PARIBAS ARBITRAGE, SNC is the third largest holder of Evogene. The company owns 91.4K of the company's shares outstanding (worth $68.55K).